ZB
TEVA icon

Zions Bancorporation’s Teva Pharmaceuticals TEVA Stock Holding History

Zions Bancorporation’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$12.8K Hold
580
– – ﹤0.01% 575
2024
Q3 		$10.5K Hold
580
– – ﹤0.01% 621
2024
Q2 		$9.43K Sell
580
-67
-10% -$1.03K ﹤0.01% 675
2024
Q1 		$9.13K Sell
647
-72
-10% -$908 ﹤0.01% 688
2023
Q4 		$7.51K Buy
719
+139
+24% +$1.3K ﹤0.01% 699
2023
Q3 		$5.92K Sell
580
-137
-19% -$1.28K ﹤0.01% 709
2023
Q2 		$5.4K Hold
717
– – ﹤0.01% 717
2023
Q1 		$6.34K Sell
717
-388
-35% -$3.84K ﹤0.01% 708
2022
Q4 		$10.1K Buy
1,105
+105
+11% +$916 ﹤0.01% 716
2022
Q3 		$8K Sell
1,000
-16
-2% -$141 ﹤0.01% 718
2022
Q2 		$8K Sell
1,016
-187
-16% -$1.63K ﹤0.01% 783
2022
Q1 		$11K Sell
1,203
-136
-10% -$1.14K ﹤0.01% 808
2021
Q4 		$11K Buy
1,339
+120
+10% +$1.08K ﹤0.01% 732
2021
Q3 		$12K Buy
1,219
+91
+8% +$852 ﹤0.01% 704
2021
Q2 		$11K Buy
1,128
+19
+2% +$201 ﹤0.01% 723
2021
Q1 		$13K Sell
1,109
-35
-3% -$401 ﹤0.01% 653
2020
Q4 		$11K Sell
1,144
-305
-21% -$2.92K ﹤0.01% 663
2020
Q3 		$13K Hold
1,449
– – ﹤0.01% 624
2020
Q2 		$18K Sell
1,449
-212
-13% -$2.4K ﹤0.01% 519
2020
Q1 		$15K Buy
1,661
+42
+3% +$430 ﹤0.01% 515
2019
Q4 		$16K Buy
1,619
+1,353
+509% +$12.1K ﹤0.01% 650
2019
Q3 		$2K Sell
266
-130
-33% -$996 ﹤0.01% 888
2019
Q2 		$4K Buy
396
+35
+10% +$422 ﹤0.01% 760
2019
Q1 		$6K Buy
+361
New +$6.37K ﹤0.01% 754
2018
Q1 		– Sell
-417
Closed -$8K – 677
2017
Q4 		$8K Buy
417
+336
+415% +$5.05K ﹤0.01% 484
2017
Q3 		$1K Buy
+81
New +$1.82K ﹤0.01% 1045
2017
Q2 		– Sell
-243
Closed -$8K – 723
2017
Q1 		$8K Buy
243
+16
+7% +$546 ﹤0.01% 423
2016
Q4 		$8K Sell
227
-144
-39% -$5.75K ﹤0.01% 559
2016
Q3 		$18K Buy
371
+79
+27% +$4.12K ﹤0.01% 399
2016
Q2 		$15K Sell
292
-116
-28% -$6.17K ﹤0.01% 388
2016
Q1 		$22K Sell
408
-41
-9% -$2.41K ﹤0.01% 378
2015
Q4 		$26K Sell
449
-7
-2% -$433 ﹤0.01% 312
2015
Q3 		$27K Buy
+456
New +$29.6K 0.01% 298
2015
Q2 		– Sell
-398
Closed -$25K – 688
2015
Q1 		$25K Buy
+398
New +$23.1K ﹤0.01% 327

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Zions Bancorporation's TEVA Position: Q4 2024 in Review

Zions Bancorporation held its Teva Pharmaceuticals (TEVA) position steady in Q4 2024 at 580 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Zions Bancorporation first reported a position in TEVA in Q1 2015 and has held it in 34 quarters since. The position peaked at $27K in Q3 2015. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Zions Bancorporation held 580 shares of Teva Pharmaceuticals worth $12.8K as of Q4 2024.
  • Zions Bancorporation left its Teva Pharmaceuticals share count unchanged in Q4 2024.
  • Teva Pharmaceuticals made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #575 holding.
  • Zions Bancorporation first reported a position in Teva Pharmaceuticals in Q1 2015 and has held it in 34 quarters since.
  • Zions Bancorporation's Teva Pharmaceuticals position peaked at $27K in Q3 2015.
  • 584 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.